The NCRI Prostate Group has two working groups that develop research in areas of strategic need.
Lack of treatments and evidence As recently as ten years ago, despite many new drugs being approved for use in prostate cancer, many men with…
Read More
Addressing problems with prostate cancer diagnosis To diagnose prostate cancer, PSA (prostate specific antigen) levels in the blood are used as an initial screening test.…
Men with higher levels of ‘free’ testosterone and a growth hormone in their blood are more likely to be diagnosed with prostate cancer, according to…